Dr. Katherine A. Janeway
Claim this profileDana-Farber Cancer Institute
Expert in Osteosarcoma
Studies Recurrence
15 reported clinical trials
25 drugs studied
Area of expertise
1Osteosarcoma
Global LeaderStage IV
Stage I
Stage II
2Recurrence
Stage I
Stage II
MTOR positive
Affiliated Hospitals
Clinical Trials Katherine A. Janeway is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Olaparib + Ceralasertib
for Recurrent Osteosarcoma
This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment The names of the study drugs involved in this study are: * Olaparib * Ceralasertib
Recruiting2 awards Phase 24 criteria
More about Katherine A. Janeway
Clinical Trial Related7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Katherine A. Janeway has experience with
- Olaparib
- Palbociclib
- Selpercatinib
- Tipifarnib
- Vemurafenib
- Genetic Testing And GAIN Report
Breakdown of trials Katherine A. Janeway has run
Osteosarcoma
Recurrence
Tumors
Neuroectodermal Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katherine A. Janeway specialize in?
Katherine A. Janeway focuses on Osteosarcoma and Recurrence. In particular, much of their work with Osteosarcoma has involved Stage IV patients, or patients who are Stage I.
Is Katherine A. Janeway currently recruiting for clinical trials?
Yes, Katherine A. Janeway is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Katherine A. Janeway has studied deeply?
Yes, Katherine A. Janeway has studied treatments such as Olaparib, Palbociclib, Selpercatinib.
What is the best way to schedule an appointment with Katherine A. Janeway?
Apply for one of the trials that Katherine A. Janeway is conducting.
What is the office address of Katherine A. Janeway?
The office of Katherine A. Janeway is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.